Esta web utiliza cookies para mejorar la experiencia del usuario. Puede obtener más información acerca del uso de cookies en el apartado Sobre las Cookies. Incluye instrucciones sobre cómo desconectarlas, si lo desea. Continuar navegando por el sitio web implica la aceptación del uso de cookies, como se describe en el apartado Sobre las Cookies.
Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic‐induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry 1999;156(11):1686‐96.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III). Washington DC: American Psychiatric Association, 1980.
APA 1987
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition‐ Revised (DSM‐III‐R). Washington, DC: American Psychiatric Association, 1987.
APA 1994
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM‐IV). Washington DC: American Psychiatric Association, 1994.
Arnt 1998
Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 1998;18:63‐101.
Cipriani A, Furukawa TA, Veronese A, Watanabe N, Churchill R, McGuire H, Barbui C. Paroxetine versus other anti‐depressive agents for depression. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006531]
Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second‐generation antipsychotics: a systematic review of one‐year studies. American Journal of Psychiatry 2004;161:414‐5.
Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623‐9.
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta‐analysis can provide accurate results. Journal of Clinical Epidemiology 2006;59:7‐10.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale ‐Brown Obsessive Compulsive Scale: Development, use and reliability. Archives of General Psychiatry 1989;46(11):1012‐6.
Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O´Keane V, Papakostas G, Vieta E, Zohar J. Advantages and disadvantages of combination treatment with antipsychotics ECNP consensus Meeting, March 2008, Nice. European Neuropsychopharmacology 2009;19:520‐32.
Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83.
Guy W. Clinical Global Impressions ‐ ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76‐338). Revised. Rockville MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH, 1976.
Hamilton 1959
Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50‐5.
Hawkridge S, Ipser JC, Stein DJ. Pharmacotherapy for anxiety disorder in children and adolescents. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005170.pub2]
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org2008.
Maia TV, Cooney RE, Petersen BS. The neural base of obsessive compulsive disorder in children and adults. Development and psychopathology 2008;20:1251‐83.
Ravindran AV, Bradbury C, McKay M, da Silva TL. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders. Expert Opinion in Pharmacotherapy 2007;8(11):1693‐710.
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive‐compulsive disorder in the National Comorbidity Survey Replication. Molecular Psychiatry 2008;epub ahead of print:no page numbers available.
World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD‐10). Geneva: World Health Organisation, 1992.
Zaudig 2002
Zaudig M, Hauke W, Hegerl U. Epidemiology, comorbidity and course of obsessive compulsive disorder [Epidemilogie, Komorbidität und Verlauf der Zwangsstörung [German]]. In: Michael Zaudig, Sabine Bosser‐Zaudig editor(s). Obsessive Compulsive Disorder: Diagnosis and Treatment [Die Zwangsstörung: Diagnostik und Therapie]. Stuttgart: Schattauer, 2002. [ISBN: 3794521455]
Todos los apartados aparecen seleccionados por defecto, por favor, seleccione los apartados que no desea imprimir o utilice el botón de seleccionar o deseleccionar todo para añadir o quitar apartados.
Seleccionar/deseleccionar todo
Los datos disponibles están protegidos por derechos de autor y sólo pueden utilizarse de acuerdo con los Términos y Condiciones.